Cullen Capital Management, LLC Novartis Ag Transaction History

Cullen Capital Management, LLC

  • $8.77 Billion
  • Q1 2024

A detailed history of Cullen Capital Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cullen Capital Management, LLC holds 2,924,424 shares of NVS stock, worth $302 Million. This represents 3.23% of its overall portfolio holdings.

Number of Shares
2,924,424
Previous 1,629,238 79.5%
Holding current value
$302 Million
Previous $165 Million 71.96%
% of portfolio
3.23%
Previous 2.5%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$95.27 - $108.47 $123 Million - $140 Million
1,295,186 Added 79.5%
2,924,424 $283 Million
Q4 2023

Feb 14, 2024
SELL
$92.27 - $101.54 $100 Million - $110 Million
-1,085,571 Reduced 39.99%
1,629,238 $165 Million
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $7.68 Million - $8.52 Million
-81,081 Reduced 2.9%
2,714,809 $277 Million
Q2 2023

Aug 14, 2023
SELL
$92.52 - $104.91 $61.4 Million - $69.7 Million
-664,113 Reduced 19.19%
2,795,890 $282 Million
Q1 2023

May 15, 2023
BUY
$80.03 - $92.81 $53.8 Million - $62.4 Million
672,290 Added 24.12%
3,460,003 $318 Million
Q4 2022

Feb 16, 2023
SELL
$75.55 - $92.52 $51.3 Million - $62.9 Million
-679,560 Reduced 19.6%
2,787,713 $253 Million
Q3 2022

Nov 10, 2022
BUY
$74.61 - $87.26 $7.76 Million - $9.07 Million
103,941 Added 3.09%
3,467,273 $264 Million
Q2 2022

Aug 11, 2022
BUY
$80.52 - $93.75 $5.48 Million - $6.38 Million
68,061 Added 2.07%
3,363,332 $284 Million
Q1 2022

May 03, 2022
BUY
$80.11 - $90.62 $39.5 Million - $44.6 Million
492,643 Added 17.58%
3,295,271 $289 Million
Q4 2021

Feb 10, 2022
SELL
$79.7 - $88.13 $15.6 Million - $17.3 Million
-196,010 Reduced 6.54%
2,802,628 $245 Million
Q3 2021

Nov 05, 2021
BUY
$81.78 - $95.14 $10.7 Million - $12.5 Million
131,051 Added 4.57%
2,998,638 $245 Million
Q2 2021

Aug 04, 2021
BUY
$85.24 - $94.15 $23.4 Million - $25.9 Million
274,919 Added 10.6%
2,867,587 $262 Million
Q1 2021

May 10, 2021
BUY
$83.5 - $98.47 $173 Million - $204 Million
2,067,642 Added 393.82%
2,592,668 $222 Million
Q4 2020

Jan 26, 2021
SELL
$78.07 - $94.43 $9.36 Million - $11.3 Million
-119,909 Reduced 18.59%
525,026 $49.6 Million
Q3 2020

Nov 02, 2020
SELL
$82.14 - $91.0 $301,043 - $333,515
-3,665 Reduced 0.57%
644,935 $56.1 Million
Q2 2020

Jul 31, 2020
SELL
$80.93 - $91.1 $9.47 Million - $10.7 Million
-117,020 Reduced 15.28%
648,600 $56.6 Million
Q1 2020

May 13, 2020
BUY
$70.67 - $99.01 $54.1 Million - $75.8 Million
765,620 New
765,620 $63.1 Million
Q1 2020

May 05, 2020
SELL
$70.67 - $99.01 $57.7 Million - $80.9 Million
-816,660 Closed
0 $0
Q4 2019

Jan 31, 2020
SELL
$84.35 - $95.37 $3.79 Million - $4.29 Million
-44,966 Reduced 5.22%
816,660 $77.3 Million
Q3 2019

Nov 15, 2019
SELL
$85.54 - $94.26 $431,121 - $475,070
-5,040 Reduced 0.58%
861,626 $74.9 Million
Q2 2019

Jul 30, 2019
SELL
$75.4 - $92.8 $415,454 - $511,328
-5,510 Reduced 0.63%
866,666 $79.1 Million
Q1 2019

May 15, 2019
BUY
$75.32 - $86.15 $566,783 - $648,278
7,525 Added 0.87%
872,176 $83.9 Million
Q4 2018

Feb 14, 2019
SELL
$73.66 - $82.02 $1.88 Million - $2.09 Million
-25,505 Reduced 2.87%
864,651 $74.2 Million
Q3 2018

Nov 15, 2018
SELL
$66.94 - $77.43 $407,999 - $471,935
-6,095 Reduced 0.68%
890,156 $76.7 Million
Q2 2018

Aug 14, 2018
BUY
$64.91 - $73.36 $188,239 - $212,744
2,900 Added 0.32%
896,251 $67.7 Million
Q1 2018

May 14, 2018
BUY
$70.39 - $84.15 $1.14 Million - $1.37 Million
16,255 Added 1.85%
893,351 $72.2 Million
Q4 2017

Feb 15, 2018
BUY
$72.33 - $77.64 $230,009 - $246,895
3,180 Added 0.36%
877,096 $73.6 Million
Q3 2017

Nov 14, 2017
SELL
$74.14 - $77.27 $1.04 Million - $1.09 Million
-14,075 Reduced 1.59%
873,916 $75 Million
Q2 2017

Aug 16, 2017
BUY
N/A
887,991
887,991 $74.1 Million

Others Institutions Holding NVS

# of Institutions
1,342
Shares Held
140M
Call Options Held
1.15M
Put Options Held
866K
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cullen Capital Management, LLC Portfolio

Follow Cullen Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cullen Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email